The Proteolytically Stable Peptidomimetic Pam-(Lys-ßNSpe)6-NH2 Selectively Inhibits Human Neutrophil Activation via Formyl Peptide Receptor 2

Sarah Line Skovbakke, Peter M. H. Heegaard, Camilla J. Larsen, Henrik Franzyk, Huamei Forsman, Claes Dahlgren

    Research output: Contribution to journalJournal articleResearchpeer-review

    454 Downloads (Pure)

    Abstract

    Immunomodulatory host defense peptides (HDPs) are considered to be lead compounds for novel anti-sepsis and anti-inflammatory agents. However, development of drugs based on HDPs has been hampered by problems with toxicity and low bioavailability due to in vivo proteolysis. Here, a subclass of proteolytically stable HDP mimics consisting of lipidated α-peptide/β-peptoid oligomers was investigated for their effect on neutrophil function. The most promising compound, Pam-(Lys-βNSpe)6-NH2, was shown to inhibit formyl peptide receptor 2 (FPR2) agonist-induced neutrophil granule mobilization and release of reactive oxygen species. The potency of Pam-(Lys-βNSpe)6-NH2 was comparable to that of PBP10, the most potent FPR2-selective inhibitor known. The immunomodulatory effects of structural analogues of Pam-(Lys-βNSpe)6-NH2 emphasized the importance of both the lipid and peptidomimetic parts. By using imaging flow cytometry in primary neutrophils and FPR-transfected cell lines we found that a fluorescently labelled analogue of Pam-(Lys-βNSpe)6-NH2 interacted selectively with FPR2. Furthermore the interaction between Pam-(Lys-βNSpe)6-NH2 and FPR2 was found to prevent binding of the FPR2-specific activating peptide agonist Cy5-WKYMWM, while the binding of a FPR1-selective agonist was not inhibited. To our knowledge, Pam-(Lys-βNSpe)6-NH2 is the first HDP mimic found to inhibit activation of human neutrophils via direct interaction with FPR2. Hence, we consider Pam-(Lys-βNSpe)6-NH2 to be a convenient tool in the further dissection of the role of FPR2 in inflammation and homeostasis as well as for investigation of the importance of neutrophil stimulation in anti-infective therapy involving HDPs.
    Original languageEnglish
    JournalBiochemical Pharmacology
    Volume93
    Issue number2
    Pages (from-to)182–195
    ISSN0006-2952
    DOIs
    Publication statusPublished - 2015

    Keywords

    • Formyl peptide receptors
    • Neutrophils
    • Anti-inflammatory
    • Host defense peptides
    • G-protein-coupled receptors

    Fingerprint Dive into the research topics of 'The Proteolytically Stable Peptidomimetic Pam-(Lys-ßNSpe)<sub>6</sub>-NH<sub>2</sub> Selectively Inhibits Human Neutrophil Activation via Formyl Peptide Receptor 2'. Together they form a unique fingerprint.

    Cite this